The Valley Desk

ArticlePharmacoEconomicsPublished

Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Penn State Abington, with Pennsylvania State University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
PharmacoEconomics
Published
Subject terms
Humans; Colorectal Neoplasms; Neoplasm Metastasis; Chromosomal Instability; Antineoplastic Combined Chemotherapy Protocols; Models, Economic; Quality-Adjusted Life Years; Cost-Benefit Analysis; Germany; Ireland; Spain; Bevacizumab
PubMed ID
41636995
Added to directory
Source checked

Report a correction or request removal